Niagen Bioscience, Inc. Common Stock NAGE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $18.64M+7.2% | $17.38M-14.9% | $20.43M+15.2% | $17.73M+25.7% | $14.11M+65.0% | ||
| $570K-6.9% | $612K-1.9% | $624K-1.1% | $631K-1.9% | $643K-3.0% | ||
| $6.71M+10.6% | $6.07M+19.6% | $5.07M+25.2% | $4.05M+8.1% | $3.75M+2.5% | ||
| $4.43M-67.2% | $13.5M-36.9% | $21.41M+0.9% | $21.21M+6.3% | $19.96M+61.3% | ||
| $4.99M+1,807% | -$292K-12.3% | -$260K-1.2% | -$257K-91.8% | -$134K+6.3% | ||
| —— | —— | —— | —— | $0— | ||
| $1.6M-77.1% | $7M-34.9% | $10.74M-7.7% | $11.64M+37.1% | $8.49M+58.1% | ||
| $10.93M-45.7% | $20.13M-36.9% | $31.89M-2.1% | $32.59M+16.2% | $28.05M+61.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Niagen Bioscience, Inc. Common Stock generate?
- Niagen Bioscience, Inc. Common Stock (NAGE) generated $4.4M in operating cash flow over the trailing twelve months.
- Where does Niagen Bioscience, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
